Radcliffe Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,029,995
Closed -$10.5M 735
2022
Q4
$10.5M Hold
1,029,995
0.33% 45
2022
Q3
$10.3M Hold
1,029,995
0.25% 47
2022
Q2
$10.2M Hold
1,029,995
0.23% 49
2022
Q1
$10.1M Sell
1,029,995
-5
-0% -$49 0.23% 45
2021
Q4
$10.1M Buy
+1,030,000
New +$10.1M 0.26% 39

Other funds holding PEPL

Radcliffe Capital Management's PEPL Position: Q1 2023 in Review

Radcliffe Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 1,029,995 shares — an estimated $10.5M sold.

Radcliffe Capital Management first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $10.5M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Radcliffe Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 1,029,995 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $10.5M.
  • Radcliffe Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Radcliffe Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $10.5M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.